FundedIQ
Biotechnology

BennuBio: Funding, Investors & Team (Sep 2026)

BennuBio is developing instruments that can use the flow cytometry paradigm to analyze samples regardless of particle size or sample volume. The company is an emerging technology company delivering unique cell analysis systems. BennuBio was founded in 2018 and based in Albuquerque, New Mexico.

bennubio.com LinkedIn Albuquerque, United States 11-50 employees
Total raised
$5.0M
Rounds
2
Latest
Undisclosed round
Jun 2023

BennuBio has raised $5.0M across 2 funding rounds on record, the most recent an undisclosed round announced in Jun 2023.

BennuBio Company Profile and Key Stats

Total funding raised
$5.0M
across 2 rounds on record
Funding rounds on record
2
1 with no disclosed amount
Latest funding round
Undisclosed round
Jun 2023
Employees
11-50
reported band
Headquarters
Albuquerque, United States

Latest funding round on record: Jun 2023.

BennuBio Funding Rounds

Date
Round
Amount
Undisclosed round
Undisclosed
Undisclosed round
$5.0M

1 of 2 rounds was announced without a disclosed amount and is excluded from the total.

BennuBio raised $5.0M in an undisclosed round announced in Apr 2020.

3.2 years later, an undisclosed round was announced in Jun 2023 with no disclosed amount.

BennuBio Founders and Leadership Team

Name
Role
Contact
James Freyer
Founder
Steven Graves
CEO

No contact details are on record for this team yet.

BennuBio Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round
4,179
$8.0M
29,722
$7.5M

Funded Startups Like BennuBio in Biotechnology and Albuquerque

Companies Similar to BennuBio

Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…

Convertible Note $6.8M

XiltriX North America is an information technology company that specializes in monitoring, predictive…

Undisclosed round $3.0M

Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…

Seed $3.1M

Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…

Series D $66.0M

Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…

Series B $92.7M

Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…

Series C $110M

InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…

Series B $77.0M

Paterna BioSciences, Inc. is a pioneering biotechnology company dedicated to solving the significant…

Series A $6.3M

Legendary Bio's solidarity is a determined spotlight on introducing another period of quality guideline.

Series C $90.0M

Cataract surgery is the single most common procedure performed in the United States annually. Despite…

Series A $7.0M

InSitu Biologics is a developer of a drug delivery platform designed to focus on development of new and…

Convertible Note $1.3M

Remedium Bio is a gene therapy company in the Boston area that is dedicated to developing cures for severe…

Series A $10.0M

BennuBio Funding FAQs

What does BennuBio do?

BennuBio is developing instruments that can use the flow cytometry paradigm to analyze samples regardless of particle size or sample volume. The company is an emerging technology company delivering unique cell analysis systems. BennuBio was founded in 2018 and based in Albuquerque, New Mexico.

How much funding has BennuBio raised?

BennuBio has raised $5.0M across 2 rounds on record.

When did BennuBio last raise funding?

BennuBio's most recent funding round on record was announced in Jun 2023. The amount was not disclosed.

Who founded BennuBio?

FundedIQ lists James Freyer (Founder) at BennuBio.

Who is the CEO of BennuBio?

Steven Graves is listed as CEO at BennuBio.

Where is BennuBio headquartered?

BennuBio is based in Albuquerque, New Mexico, United States.

How many employees does BennuBio have?

BennuBio is in the 11-50 employee band.

About FundedIQ's BennuBio Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for BennuBio is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.

Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.